Symptoms of the problem include abdominal swelling, bloating, constipation, diarrhoea, vomiting and an inability to pass gas
Regular monitoring is essential : attend all scheduled appointments with your diabetes team, where your HbA1c, weight, renal function, and overall tolerability will be assessed
Wegovy Data as Reported by Novo Nordisk The manufacturers language on the weight loss indication reads thus: Wegovy (semaglutide) injection 2.4 mg is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity and adults with overweight in the presence of at least one weight-related comorbidity. At two years, patients taking Wegovy showed a mean weight loss of 15% or 34 pounds, from a mean baseline BMI of 38.5
Across all three pathways, one pattern holds without exception: the patients who maintain results at 12 and 24 months are not the ones who chose the most aggressive procedure
Frequently Asked Questions (FAQs) Take the Next Step Toward Your Health Goals While we await the final approval of Retatrutide, you dont have to wait to start your transformation